A preclinical study found that exercise counteracts the depressive-like effects of a high-fat, high-sugar “cafeteria” diet. Exercise improved mood-related behavior and partially normalized hormone imbalances (reducing insulin and leptin while increasing GLP-1 and PYY)
submitted by /u/mustaphah [link] [comments]
Compounded GLP-1 Plans at hims From $249/month
hims is offering Compounded GLP-1 plans with savings of up to $50 per month. Get the 6-month plan for $199/month ($50 off), the 4-month plan for $249/month ($50 off), and the 2-month plan for $325/month ($24 off). Buy Now at hims
Illegal GLP-1 compounding puts Coloradans at risk
By Laura Howard In 2024, Black or African-American adults were 28% more likely to be obese than adults of the total population. This stark health disparity is one of many concerns the Colorado Council
5 Mistakes I Made When I Started A GLP-1
Weight loss medications can be lifesaving for people who need them — but there are errors you’ll want to avoid.
Here’s How Eli Lilly’s Oncology Drugs Are Poised Ahead of Q3 Earnings
While Eli Lilly LLY is a market leader in the GLP-1 segment, thanks to its tirzepatide medicines Mounjaro and Zepbound (for obesity), the company also generates a meaningful portion of revenues from its oncology franchise. Sales from the oncology drugs accounted for more than 15% of Lilly’s first-half 2025 revenues, which grew about 10% year […]
STAT+: Ro wants to measure ‘food noise’ in obesity care
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, you’ve made it Friday! We’ve got some more news to get through before heading into the weekend. FDA delivers split decision on GSK’s Blenrep The Food and Drug Administration yesterday delivered a […]
A New Chapter in Diabetes and Obesity Care: Local Access to Advanced GLP-1 and GIP RA Therapies
Pakistan’s healthcare landscape has entered a pivotal phase in the management of diabetes and obesity. For years, advanced incretin-based therapies, known globally for their role in blood sugar and weight control, remained out of reach for most local patients due to high import costs and limited supply. That gap is now beginning to close. What […]
STAT+: Can ‘food noise’ be measured? Telehealth giant Ro rolls out a new scale for obesity care
Telehealth companies that have seized on the boom in weight loss drugs are playing a bigger role not just in treating patients with obesity, but also shaping how the medical mainstream understands obesity. A dominant player in the field, Ro, said Friday it has launched a new questionnaire designed to measure “food noise,” a term […]
Opinion: Trump’s $150-per-month GLP-1 plan won’t reach people like me
On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy to $150 a month. Even after a top health official suggested price negotiations between drugmakers and the administration were ongoing, the announcement sent Novo Nordisk and Eli Lilly stocks tumbling. For patients who’ve been priced out, that […]
GLP-1s May Protect Against AMD in Those Without Diabetes
People without diabetes who receive GLP-1 receptor agonists for the treatment of overweight or obesity face a reduced risk of developing dry age-related macular degeneration, a recent study shows. Medscape Medical News